| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 12/20/2007 | US20070293521 inhibitors of immunoglobulin E or G receptor signaling cascades; Syk kinase inhibitors; use as antiallergic, antiinflammatory agents |
| 12/20/2007 | US20070293520 2,4-pyrimidinediamine compounds and their uses |
| 12/20/2007 | US20070293519 Analogs of thalidomide as potential angiogenesis inhibitors |
| 12/20/2007 | US20070293518 Prolonged improvement of renal function comprising infrequent administration of an aa1ra |
| 12/20/2007 | US20070293517 Derivatives Of Chemotherapeutic Agents With A Formaldehyde Releasing Moiety |
| 12/20/2007 | US20070293516 Kinase antagonists |
| 12/20/2007 | US20070293515 1,3-Disubstituted Heteroaryl Nmda/Nr2b Antagonists |
| 12/20/2007 | US20070293513 Cristalline and amorphous form of a triazolo (4,5-d) pyridimine compound |
| 12/20/2007 | US20070293512 2-[4-(4-Chlorophenylthio)-3-nitrophenyl]-4-mercaptothiazolo[5,4-d]pyrimidine; hyperuricemia; gout |
| 12/20/2007 | US20070293511 Crf Receptor Antagonists and Methods |
| 12/20/2007 | US20070293509 treating eating disorders, obesity, type II diabetes, and substance abuse and/or addiction (including alcohol dependency and nicotine dependency); 6-(4-chloro-phenyl)-5-[methyl-(3-methyl-butyl)-amino]-pyrazine-2-carboxylic acid ((R)-2-cyclopropyl-2-hydroxy-propyl)-amide |
| 12/20/2007 | US20070293508 Crf Receptor Antagonists and Methods Relating Thereto |
| 12/20/2007 | US20070293507 Pyrazole Kinase Modulators And Methods Of Use |
| 12/20/2007 | US20070293506 Combination preparations comprising bifeprunox and a dopamine agonist |
| 12/20/2007 | US20070293505 Combination preparations comprising slv308 and a dopamine agonist |
| 12/20/2007 | US20070293504 N-phenyl-2-pyrimidine-amine derivatives |
| 12/20/2007 | US20070293503 Phenylenediamine urotensin-II receptor antagonists and CCR-9 antagonists |
| 12/20/2007 | US20070293502 Diarylmethyl Piperazine Derivatives, Preparations Thereof and Uses Thereof |
| 12/20/2007 | US20070293501 Thioalkeneamides as Transketolase Inhibitors |
| 12/20/2007 | US20070293500 Quinazoline derivatives as medicaments |
| 12/20/2007 | US20070293499 Intracellular Kinase Inhibitors |
| 12/20/2007 | US20070293498 used for the treatment of cachexia and other weight loss disorders, such as those resulting from cancer, HIV, old age and anorexia nervosa |
| 12/20/2007 | US20070293497 2,3,4,6-Substituted Pyridyl Derivative Compounds Useful As Beta-Secretase Inhibitors For The Treatment Of Alzheimer's Disease |
| 12/20/2007 | US20070293496 Nitrogen containing heterocyclic compounds and medicines containing the same |
| 12/20/2007 | US20070293495 to treat Alzheimer's disease,Down syndrome and the other diseases associated with amyloid deposition; thiomethane, sulfinylmethane or sulfonylmethane compounds; 5-Chloro-4-[(4-chlorophenylsulfonyl)-(2,5-difluorophenyl)methyl]-2-(4'-hydroxypiperidin-1'-yl)pyridine |
| 12/20/2007 | US20070293494 2-Anilino-4-(Heterocyclic) Amino-Pyrimidines |
| 12/20/2007 | US20070293493 Oxazolidinone antibiotics and derivatives thereof |
| 12/20/2007 | US20070293492 Quinoline Tachykinin Receptor Antagonists |
| 12/20/2007 | US20070293491 Indazole compounds and methods for inhibition of cdc7 |
| 12/20/2007 | US20070293490 Quinazoline Derivatives |
| 12/20/2007 | US20070293489 Substituted Pyrazolopyrimidines |
| 12/20/2007 | US20070293488 tyrosine kinase inhibitors such as 1-(2-fluoro-5-trifluoromethylphenyl)-3-[4-(5-oxo-5,8-dihydropyrido[2,3-d]pyrimidin-4-ylamino)phenyl]urea, used as antitumor or anticarcinogenic agents or for the treatment of psoriasis, arthritis, retinopathy or dermatitis |
| 12/20/2007 | US20070293487 Benzothiazole- and benzooxazole-4,7-dione, derivatives and their use as cdc25 phosphate inhibitors |
| 12/20/2007 | US20070293486 Alpha-Keto Carbonyl Calpain Inhibitors |
| 12/20/2007 | US20070293485 Drug administration methods |
| 12/20/2007 | US20070293484 Thiophene Heteroaryl Amines |
| 12/20/2007 | US20070293483 Acetyl 2-hydroxy-1, 3-diaminoalkanes |
| 12/20/2007 | US20070293482 Process for Preparing Benzodiazepines |
| 12/20/2007 | US20070293481 Treating obesity with muscarinic receptor m1 antagonists |
| 12/20/2007 | US20070293480 Treating psychological conditions using muscarinic receptor m1 antagonists |
| 12/20/2007 | US20070293479 Olanzapine pharmaceutical composition |
| 12/20/2007 | US20070293478 such as 1-Cyclopropyl-N-(2,4-dichlorobenzyl)-6-fluoro-8-methoxy-7-[3-methyl-4-(2-{[(methylamino)carbonyl]amino}-2-oxoethyl)piperazin-1-yl]-4-oxo-1,4-dihydroquinoline-3-carboxamide, used for the treatment and/or prophylaxis of viral diseases or infections, particularly against cytomegaloviruses |
| 12/20/2007 | US20070293477 Novel Compounds |
| 12/20/2007 | US20070293476 Co-therapy for the treatment of epilepsy and related disorders |
| 12/20/2007 | US20070293475 Aryl and heteroaryl tetrahydrobenzazepine derivatives and their use for treating glaucoma |
| 12/20/2007 | US20070293474 Combination of a DPP IV inhibitor and a cardiovascular compound |
| 12/20/2007 | US20070293473 Use of acylaminoalkenylene-amide derivatives in functional motility disorders of the viscera |
| 12/20/2007 | US20070293472 Novel 14 and 15 Membered Ring Compounds |
| 12/20/2007 | US20070293471 by reaction of 11-piperazinyldibenzo[b,f][1,4]-thiazepine with 2-(2-chloroethoxy)ethanol in presence of organic or inorganic base (such as sodium carbonate, sodium bicarbonate, potassium carbonate) under neat or aqueous condition, in presence of phase transfer catalyst (tetrabutylammonium bromide) |
| 12/20/2007 | US20070293470 Carboxamide Spirolactam Cgrp Receptor Antagonists |
| 12/20/2007 | US20070293469 Compositions and methods for the treatment and prevention of disease |
| 12/20/2007 | US20070293468 Reacting indazolium hydrochloride with Sodium tetrachlorobisindazoleruthenate(III) to form trans-Indazolium [tetrachlorobisindazoleruthenate(III)] (KP1019), and sodium chloride; both highly effective and water soluble; bioavailability; cancer treatment |
| 12/20/2007 | US20070293467 Demethyl-Cantharidin Platinum Complex Isomers and Their Use |
| 12/20/2007 | US20070293466 Antimicrobial Chelates |
| 12/20/2007 | US20070293465 Compounds for enzyme inhibition |
| 12/20/2007 | US20070293464 Substituted Pyrimidine Compositions and Methods of Use |
| 12/20/2007 | US20070293463 Method for shortening hospital stay in patients with congestive heart failure and acute fluid overload |
| 12/20/2007 | US20070293462 Method for Inhibiting Cellular Na+-K+ ATPase Activity |
| 12/20/2007 | US20070293461 Biphenyl compounds useful as muscarinic receptor antagonists |
| 12/20/2007 | US20070293460 Delivery of a combination therapy for asthma and chronic obstructive pulmonary disease |
| 12/20/2007 | US20070293459 Method for Inhibiting Cellular Na+-K+ ATPase Activity |
| 12/20/2007 | US20070293458 Prevention of nuclear, solar, and other radiation-induced tissue damage |
| 12/20/2007 | US20070293457 Boron-containing small molecules as anti-inflammatory agents |
| 12/20/2007 | US20070293456 Method for the synthesis of 3-substituted indolizine and benzoindolizine compounds |
| 12/20/2007 | US20070293454 Complex Containing Mequitazine, a Cyclodextrin and an Interaction Agent |
| 12/20/2007 | US20070293453 Combinatorial Methods For Inducing Cancer Cell Death |
| 12/20/2007 | US20070293452 Agents, compositions and methods for treating pathologies in which regulating an ache-associated biological pathway is beneficial |
| 12/20/2007 | US20070293450 Identification of ses-3 and the uses of same |
| 12/20/2007 | US20070293448 Synthetic gagpol genes and their uses |
| 12/20/2007 | US20070293447 Gene Therapy for Skin Disorders Using Needleless Syringes |
| 12/20/2007 | US20070293446 Compositions comprising C-13 alkoxyether macrolide compounds and phenylpyrazole compounds |
| 12/20/2007 | US20070293445 Stable Elsamitrucin Salts Suitable for Pharmaceutical Formulations |
| 12/20/2007 | US20070293444 Novel Nucleoside Transport Inhibitors |
| 12/20/2007 | US20070293443 Composition for Accelerating Calcium Absorption |
| 12/20/2007 | US20070293442 Antithrombotic compound |
| 12/20/2007 | US20070293441 High-pressure sterilization to terminally sterilize pharmaceutical preparations and medical products |
| 12/20/2007 | US20070293440 O-fused heterocycle sulfonylurea compounds with another anticonvulsant or antiepileptic agent such as carbamazepine |
| 12/20/2007 | US20070293439 Methods and Compositions for Treating Hyperglycemic, Hyperlipidemic, or Hyperinsulinemic Disorders |
| 12/20/2007 | US20070293436 Cytoprotective thereapeutic agents for the prevention of reperfusion injury following ischemic stroke |
| 12/20/2007 | US20070293433 Methods of treating aging of skin with oligosaccharides in cosmetic or dermatological compositions that stimulate adhesion of keratinocytes to major proteins of the dermoepidermal junction and restore epidermal cohesion |
| 12/20/2007 | US20070293428 Methods of treating joint pain in a subject by using an anti-angiogenic agent |
| 12/20/2007 | US20070293427 Glycosaminoglycans; food complements, medicaments; joint pain, obesity; bioavailability |
| 12/20/2007 | US20070293425 Mutein of a Bone Morphogenetic Protein and Use Thereof |
| 12/20/2007 | US20070293423 Compounds, Methods and Formulations for the Oral Delivery of a Glucagon-Like Peptide (Glp)-1 Compound or a Melanocortin-4 Receptor (Mc4) Agonist Peptide |
| 12/20/2007 | US20070292933 Inhibitors of serine proteases, particular HCV NS3-NS4A protease |
| 12/20/2007 | US20070292883 Method of treating diseases with PARP inhibitors |
| 12/20/2007 | US20070292545 Anti-infective agents and methods of use |
| 12/20/2007 | US20070292539 Anti-inflammatory cranberry flavonol extract preparations |
| 12/20/2007 | US20070292538 Formulation for hair growth |
| 12/20/2007 | US20070292536 Composition and method for treating patients with high neurotransmitter levels |
| 12/20/2007 | US20070292535 Strontium compositions and methods of treating arthritic and or osteoporitic conditions |
| 12/20/2007 | US20070292534 Antacid and breath freshening composition |
| 12/20/2007 | US20070292532 Vanadium Compounds as Inhibitors of Phosphatases |
| 12/20/2007 | US20070292531 Composition for oral use and methods for application of same |
| 12/20/2007 | US20070292529 Strontium compositions and methods of treating osteoporotic conditions |
| 12/20/2007 | US20070292523 Dihydropyrimidine Formulations |
| 12/20/2007 | US20070292519 Method of producing a nicotine medicament and a medicament made by the method |
| 12/20/2007 | US20070292515 Solid dosage form containing a taste masked active agent |
| 12/20/2007 | US20070292513 Pazopanib hydrochloride and synthesis, chemical intermediates, and dosage forms thereof; anticancer; colon cancer, breast cancer |
| 12/20/2007 | US20070292512 Solid Oral Dosage Form Containing an Enhancer |